Fecal Microbiome Analysis May Help Predict Colon Adenoma Prevalence, Lifetime Risk for Colorectal Cancer
Investigators examined differences in the microbiomes of patients with colorectal neoplasia.
Investigators examined differences in the microbiomes of patients with colorectal neoplasia.
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
NSAIDs target stem cells that have accumulated mutations that could lead to cancer development and a biochemical pathway that leads to apoptosis.
Reasons behind rise in colorectal cancer unclear, and it’s happening even as rates decline among older Americans.
Fecal immunochemical testing may be as effective as colonoscopies in being able to detect colorectal cancer risk.
The new test is more sensitive than fecal occult blood tests but carries a higher risk of false-positives.
Changes to Medicaid reimbursements can improve cancer screening rates.
Second study shows no benefit from CRC screening more intensively than recommended.
The FDA has appproved Cologuard, the first non-invasive DNA screening test for colorectal cancer.
Narrow band imaging may improve visualization of polyps during colonoscopy, but there are still questions as to whether it is a truly useful screening tool.